Executive Summary
Isagro S.p.A., together with its subsidiaries, engages in the research and development, manufacturing, marketing, and distribution of agro pharmaceuticals products for crop protection and nutrition in Europe, Asia, North America, and South America. More Details
Rewards
Risk Analysis
Snowflake Analysis
Adequate balance sheet with moderate growth potential.
Similar Companies
Share Price & News
How has Isagro's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ISG is not significantly more volatile than the rest of Italian stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: ISG's weekly volatility (5%) has been stable over the past year.
Market Performance
7 Day Return
-0.9%
ISG
-1.8%
IT Chemicals
-2.2%
IT Market
1 Year Return
-9.1%
ISG
12.0%
IT Chemicals
-11.1%
IT Market
Return vs Industry: ISG underperformed the Italian Chemicals industry which returned 12% over the past year.
Return vs Market: ISG exceeded the Italian Market which returned -11.2% over the past year.
Shareholder returns
| ISG | Industry | Market | |
|---|---|---|---|
| 7 Day | -0.9% | -1.8% | -2.2% |
| 30 Day | 0% | 2.2% | 0.5% |
| 90 Day | 4.2% | 6.3% | 13.3% |
| 1 Year | -9.1%-9.1% | 15.7%12.0% | -8.3%-11.1% |
| 3 Year | -47.9%-47.9% | 10.7%-0.1% | -3.9%-14.0% |
| 5 Year | -14.3%-16.4% | 69.0%43.1% | 25.4%-9.3% |
Long-Term Price Volatility Vs. Market
How volatile is Isagro's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall St
What Did Isagro's (BIT:ISG) CEO Take Home Last Year?4 months ago | Simply Wall St
Health Check: How Prudently Does Isagro (BIT:ISG) Use Debt?7 months ago | Simply Wall St
Estimating The Fair Value Of Isagro S.p.A. (BIT:ISG)Valuation
Is Isagro undervalued compared to its fair value and its price relative to the market?
0.46x
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: ISG (€1.11) is trading above our estimate of fair value (€0.42)
Significantly Below Fair Value: ISG is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: ISG is unprofitable, so we can't compare its PE Ratio to the XE Chemicals industry average.
PE vs Market: ISG is unprofitable, so we can't compare its PE Ratio to the Italian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate ISG's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: ISG is good value based on its PB Ratio (0.5x) compared to the XE Chemicals industry average (2.1x).
Next Steps
Future Growth
How is Isagro forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
0.9%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ISG's forecast earnings growth (0.9% per year) is below the savings rate (1.9%).
Earnings vs Market: ISG is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ISG's is expected to become profitable in the next 3 years.
Revenue vs Market: ISG's revenue (4.8% per year) is forecast to grow faster than the Italian market (3.2% per year).
High Growth Revenue: ISG's revenue (4.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ISG's Return on Equity is forecast to be high in 3 years time
Next Steps
Past Performance
How has Isagro performed over the past 5 years?
-69.9%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ISG is currently unprofitable.
Growing Profit Margin: ISG is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: ISG is unprofitable, and losses have increased over the past 5 years at a rate of 69.9% per year.
Accelerating Growth: Unable to compare ISG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ISG is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-12%).
Return on Equity
High ROE: ISG has a negative Return on Equity (-9.05%), as it is currently unprofitable.
Next Steps
Financial Health
How is Isagro's financial position?
Financial Position Analysis
Short Term Liabilities: ISG's short term assets (€96.3M) exceed its short term liabilities (€45.2M).
Long Term Liabilities: ISG's short term assets (€96.3M) exceed its long term liabilities (€21.7M).
Debt to Equity History and Analysis
Debt Level: ISG's debt to equity ratio (46.7%) is considered high.
Reducing Debt: ISG's debt to equity ratio has reduced from 68.9% to 46.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ISG has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ISG has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
Next Steps
Dividend
What is Isagro current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ISG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ISG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ISG's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ISG's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: ISG is not paying a notable dividend for the Italian market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ISG's dividend in 3 years as they are not forecast to pay a notable one for the Italian market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
1.0yrs
Average management tenure
CEO
Giorgio Basile
no data
Tenure
€503,708
Compensation
Mr. Giorgio Basile serves as the Chairman, Chief Executive Officer, President and Managing Director at Isagro SPA. Mr. Basile serves as the President of Manisa Srl. He is a Member of Advisory Committee at ...
CEO Compensation Analysis
Compensation vs Market: Giorgio's total compensation ($USD609.00K) is above average for companies of similar size in the Italian market ($USD339.18K).
Compensation vs Earnings: Giorgio's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | no data | €503.71k | no data | |
| Executive Deputy Chairman & Executive VP | no data | €90.18k | no data | |
| CFO & Financial Manager | 8.67yrs | no data | no data | |
| Chief Operating Officer | 1yr | no data | no data | |
| IR Manager & Financial Planner | no data | no data | no data | |
| Head of Corporate Development and Internal Relations | no data | no data | no data | |
| Group Director Marketing & Business Development | 1yr | no data | no data | |
| Group Director Sales | 0.25yr | no data | no data | |
| Board Secretary | 0.33yr | no data | no data |
1.0yrs
Average Tenure
Experienced Management: ISG's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | no data | €503.71k | no data | |
| Executive Deputy Chairman & Executive VP | no data | €90.18k | no data | |
| Director | 2.75yrs | €20.00k | no data | |
| Director | no data | €20.00k | no data | |
| Independent Director | 4.75yrs | €27.00k | no data | |
| Non-Executive Director | 2.75yrs | €20.00k | no data | |
| Non-Executive Director | 2.75yrs | €20.00k | no data | |
| Independent Director | 2.75yrs | €27.50k | no data | |
| Independent Director | 2.75yrs | €27.00k | no data | |
| Lead Independent Director | 2.67yrs | €25.00k | no data | |
| Independent Director | 2.75yrs | €23.00k | no data | |
| Chairman of Statutory Auditor | 1.75yrs | no data | no data |
2.8yrs
Average Tenure
Experienced Board: ISG's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Isagro S.p.A.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Isagro S.p.A.
- Ticker: ISG
- Exchange: BIT
- Founded: 1992
- Industry: Fertilizers and Agricultural Chemicals
- Sector: Materials
- Market Cap: €39.748m
- Shares outstanding: 37.83m
- Website: https://www.isagro.com
Number of Employees
Location
- Isagro S.p.A.
- Via Caldera, 21
- Milan
- Milan
- 20153
- Italy
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| ISG | BIT (Borsa Italiana) | Yes | Ordinary Shares | IT | EUR | Nov 2003 |
| 0ESX | LSE (London Stock Exchange) | Yes | Ordinary Shares | GB | EUR | Nov 2003 |
| ISGM | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Ordinary Shares | GB | EUR | Nov 2003 |
| ISGS | BIT (Borsa Italiana) | Development Shares | IT | EUR | May 2014 | |
| 0QUE | LSE (London Stock Exchange) | Development Shares | GB | EUR | May 2014 | |
| ISGSM | BATS-CHIXE (BATS 'Chi-X Europe') | Development Shares | GB | EUR | May 2014 |
Biography
Isagro S.p.A., together with its subsidiaries, engages in the research and development, manufacturing, marketing, and distribution of agro pharmaceuticals products for crop protection and nutrition in Euro...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/01/16 18:42 |
| End of Day Share Price | 2021/01/15 00:00 |
| Earnings | 2020/09/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.